TITLE

A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder

AUTHOR(S)
Feijó Mello, Marcelo; Sau Ling Yeh, Mary; Barbosa Neto, Jair; Lorens Braga, Luciana; Fiks, Jose Paulo; Mendes, Daniela Deise; Moriyama, Tais S.; Marques Valente, Nina Leão; Pupo Costa, Mariana Caddrobi; Mattos, Patricia; Affonseca Bressan, Rodrigo; Baxter Andreoli, Sergio; Mari, Jair Jesus
PUB. DATE
January 2009
SOURCE
BMC Psychiatry;2009, Vol. 9, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Topiramate might be effective in the treatment of posttraumatic stress disorder (PTSD) because of its antikindling effect and its action in both inhibitory and excitatory neurotransmitters. Open-label studies and few controlled trials have suggested that this anticonvulsant may have therapeutic potential in PTSD. This 12-week randomized, double-blind, placebo-controlled clinical trial will compare the efficacy of topiramate with placebo and study the tolerability of topiramate in the treatment of PTSD. Methods and design: Seventy-two adult outpatients with DSM-IV-diagnosed PTSD will be recruited from the violence program of Federal University of São Paulo Hospital (UNIFESP). After informed consent, screening, and a one week period of wash out, subjects will be randomized to either placebo or topiramate for 12 weeks. The primary efficacy endpoint will be the change in the Clinician-administered PTSD scale (CAPS) total score from baseline to the final visit at 12 weeks. Discussion: The development of treatments for PTSD is challenging due to the complexity of the symptoms and psychiatric comorbidities. The selective serotonin reuptake inhibitors (SSRIs) are the mainstream treatment for PTSD, but many patients do not have a satisfactory response to antidepressants. Although there are limited clinical studies available to assess the efficacy of topiramate for PTSD, the findings of prior trials suggest this anticonvulsant may be promising in the management of these patients. Trial Registration: NCT 00725920
ACCESSION #
42408655

 

Related Articles

  • Antipsychotics in dementia raise mortality.  // GP: General Practitioner;10/21/2005, p137 

    This article reports on a U.S. study, which has found that atypical antipsychotics prescribed for dementia increase the risk of death in older patients. U.S. researchers analysed 15 trials including 5,510 patients with dementia who were randomised to receive either an atypical antipsychotic or a...

  • Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. Baldwin, David S.; Huusom, Anna Karina Trap; Æhlum, Eli M.; Maehlum, Eli // British Journal of Psychiatry;Sep2006, Vol. 189, p264 

    Background: It is uncertain whether higher doses of selective serotonin reuptake inhibitors have greater efficacy in generalised anxiety disorder.Aims: To assess the efficacy of different doses of escitalopram in generalised anxiety disorder.Method:...

  • Nefazodone and imipramine in major depression: a placebo-controlled trial. Rickels, Karl; Schweizer, Edward; Clary, Cathryn; Fox, Ira; Weise, Charles; Rickels, K; Schweizer, E; Clary, C; Fox, I; Weise, C // British Journal of Psychiatry;Jun94, Vol. 164, p802 

    Nefazodone is a phenylpiperazine antidepressant with 5-HT2 antagonism and 5-HT reuptake inhibition. Two hundred and eighty-three out-patients with a diagnosis of DSM-III-R major depression of at least one-month duration (65% ill for over 6 months), and a mean score of 24 on the 17-item Hamilton...

  • Hypnosis in the Treatment of Post-Traumatic Stress Disorder. Appelbaum, Stephen A. // American Journal of Psychotherapy;Apr1988, Vol. 42 Issue 2, p332 

    Reviews the book 'Hypnosis in the Treatment of Post-Traumatic Stress Disorder: A Case of Awareness Under Surgical Anesthesia,' by Mary Jo Peebles and Vernon Fisher Jr.

  • Knowledge and Use of Placebos by House Officers and Nurses. Goodwin, James S.; Goodwin, Jean M.; Vogel, Albert V. // Annals of Internal Medicine;Jul79, Vol. 91 Issue 1, p106 

    Talks about the level of knowledge of house officers and registered nurses in a university teaching hospital, regarding placebo action and their patterns of placebo use. Knowledge of placebo action; Patterns of placebo use by physicians and nursing staff; Discussion on the use of placebo to...

  • Placebo effects: clinical aspects and neurobiology.  // Brain: A Journal of Neurology;Nov2008, Vol. 131 Issue 11, p2812 

    Placebo effects are beneficial health outcomes not related to the relatively direct biological effects of an intervention and can be elicited by an agent that, by itself, is inert. Understanding these placebo effects will help to improve clinical trial design, especially for interventions such...

  • Does Compensation Status Influence Treatment Participation and Course of Recovery from Post-Traumatic Stress Disorder? Laffaye, Charlene; Rosen, Craig S.; Schnurr, Paula P.; Friedman, Matthew J. // Military Medicine;Oct2007, Vol. 172 Issue 10, p1039 

    We reviewed the empirical literature to examine how seeking compensation and/or being awarded compensation for posttraumatic stress disorder-related disability are associated with participation in mental health treatment and course of recovery. The search for relevant literature was conducted...

  • Early effects of mirtazapine on emotional processing. Arnone, D.; Horder, J.; Cowen, P.; Harmer, C. // Psychopharmacology;May2009, Vol. 203 Issue 4, p685 

    Acute administration of selective serotonin and noradrenaline re-uptake blockers to healthy volunteers affects the processing of emotional information but it is not known if similar effects occur with antidepressants acting through other pharmacological mechanisms. Mirtazapine is a clinically...

  • Trauma and Its Wake Vol. I: The Study and Treatment of Post-Traumatic Stress Disorder. Bird, J. M. // British Journal of Psychiatry;Mar88, Vol. 152, p450 

    The article reviews the book "Trauma and Its Wake: The Study and Treatment of Post-Traumatic Stress Disorder," vol. 1, edited by Charles R. Figley.

Share

Other Topics